Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission

Virgilio Galvis; Nathalia J. Moreno; Alejandro Tello; Néstor I. Carreño

doi:10.1136/bcr-2020-240994

Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission

Virgilio Galvis, Nathalia J. Moreno, Alejandro Tello, Néstor I. Carreño

Resultado de la investigación: Artículos / Notas › Artículo Científico › revisión exhaustiva

Resumen

A man with a history of blind eye due to trauma 22 years earlier consulted at 53 years of age with a large conjunctival neoplastic lesion, compromising almost the entire temporal limbus, and reaching a size of approximately 16 mm on its larger diameter, in the conjunctiva. Management was started with topical and subconjunctival chemotherapy (interferon alpha-2b) in order to perform immunoreduction, but a dramatic response with total disappearance of the lesion was observed. In the follow-up time period of more than 7 years, there were no signs of recurrence.

Idioma original	Inglés
Número de artículo	e240994
Publicación	BMJ Case Reports
Volumen	14
N.º	2
DOI	https://doi.org/10.1136/bcr-2020-240994
Estado	Publicada - 19 feb. 2021

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1136/bcr-2020-240994

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{0f8fcb4bac574db9ae3ef2bc94aeb872,

title = "Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission",

abstract = "A man with a history of blind eye due to trauma 22 years earlier consulted at 53 years of age with a large conjunctival neoplastic lesion, compromising almost the entire temporal limbus, and reaching a size of approximately 16 mm on its larger diameter, in the conjunctiva. Management was started with topical and subconjunctival chemotherapy (interferon alpha-2b) in order to perform immunoreduction, but a dramatic response with total disappearance of the lesion was observed. In the follow-up time period of more than 7 years, there were no signs of recurrence.",

keywords = "cancer intervention, eye, ophthalmology",

author = "Virgilio Galvis and Moreno, {Nathalia J.} and Alejandro Tello and Carre{\~n}o, {N{\'e}stor I.}",

note = "Publisher Copyright: {\textcopyright} BMJ Publishing Group Limited 2020.",

year = "2021",

month = feb,

day = "19",

doi = "10.1136/bcr-2020-240994",

language = "Ingl{\'e}s",

volume = "14",

journal = "BMJ Case Reports",

issn = "1757-790X",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Topical interferon alpha-2b for a giant ocular surface squamous neoplasia

T2 - 7 years of follow-up after complete remission

AU - Galvis, Virgilio

AU - Moreno, Nathalia J.

AU - Tello, Alejandro

AU - Carreño, Néstor I.

N1 - Publisher Copyright: © BMJ Publishing Group Limited 2020.

PY - 2021/2/19

Y1 - 2021/2/19

N2 - A man with a history of blind eye due to trauma 22 years earlier consulted at 53 years of age with a large conjunctival neoplastic lesion, compromising almost the entire temporal limbus, and reaching a size of approximately 16 mm on its larger diameter, in the conjunctiva. Management was started with topical and subconjunctival chemotherapy (interferon alpha-2b) in order to perform immunoreduction, but a dramatic response with total disappearance of the lesion was observed. In the follow-up time period of more than 7 years, there were no signs of recurrence.

AB - A man with a history of blind eye due to trauma 22 years earlier consulted at 53 years of age with a large conjunctival neoplastic lesion, compromising almost the entire temporal limbus, and reaching a size of approximately 16 mm on its larger diameter, in the conjunctiva. Management was started with topical and subconjunctival chemotherapy (interferon alpha-2b) in order to perform immunoreduction, but a dramatic response with total disappearance of the lesion was observed. In the follow-up time period of more than 7 years, there were no signs of recurrence.

KW - cancer intervention

KW - eye

KW - ophthalmology

UR - http://www.scopus.com/inward/record.url?scp=85101279171&partnerID=8YFLogxK

U2 - 10.1136/bcr-2020-240994

DO - 10.1136/bcr-2020-240994

M3 - Artículo Científico

C2 - 33608345

AN - SCOPUS:85101279171

SN - 1757-790X

VL - 14

JO - BMJ Case Reports

JF - BMJ Case Reports

IS - 2

M1 - e240994

ER -

Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto